drugset / Trial / NCT01010282

Safety and Efficacy of Two Artificial Tears in Dry Eye Subjects

NCT01010282 ↗

Completed 288 enrolled Allergan
RandomizedParallel-groupDouble-blind

Summary

This study will evaluate the safety, efficacy, and acceptability of two artificial tears compared to a currently available artificial tear in subjects with dry eye.

Timeline

Start
2009-11
Primary completion
2010-04
Completion
2010-04

Outcome

Met primary endpoint

paper the 2 lipid-based formulations were noninferior to DET in reducing the severity of symptoms of dryness at 90 days. PMID 25659956 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject ADV1 Other / unclassified — Topical
Subject ADV2 Other / unclassified — Topical
Comparator DET Other / unclassified — Topical

Indications